J&J has opted to step away from the Covid vaccine field due to a lack of demand and public trust.
via dailymail.co.uk:
The Food and Drug Administration (FDA) has revoked authorization of Johnson & Johnson’s Covid vaccine after it was paused over rare blood clot concerns, which sent demand plummeting.
The move was not unexpected because J&J’s parent company Jannsen had requested that federal regulators at the FDA withdraw authorization for its vaccine after it was revealed that the last tranche of doses – about 12.5 million – had expired.
As of year three of the Covid pandemic, nearly 231 million Americans have received either one J&J shot or two doses of an mRNA vaccine from Pfizer or Moderna.
Vaccination fatigue has swept the US, with millions of Americans frustrated by the fact that a shot does not guarantee immunity from the virus but rather protects against severe illness, and all those who had planned on getting fully vaccinated are believed to have done so by now.
With a renewed wave of demand for J&J’s single-dose vaccine highly unlikely, coupled with a beleaguered history of production hiccups and health concerns that severely eroded public trust, the pharmaceutical company has opted to step away from the Covid vaccine field.
AC
Views: 100